70 related articles for article (PubMed ID: 20950119)
1. 5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: a clinical experience.
Podolsky L; Oh M; Subbarayan PR; Francheschi D; Livingstone A; Ardalan B
Acta Oncol; 2011 May; 50(4):602-5. PubMed ID: 20950119
[No Abstract] [Full Text] [Related]
2. A phase I study of 5-fluorouracil/leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma.
Ardalan B; Subbarayan PR; Ramos Y; Gonzalez M; Fernandez A; Mezentsev D; Reis I; Duncan R; Podolsky L; Lee K; Lima M; Ganjei-Azar P
Clin Cancer Res; 2010 Jun; 16(11):3019-27. PubMed ID: 20501625
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU.
Subbarayan PR; Lee K; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1157-62. PubMed ID: 20530422
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
[TBL] [Abstract][Full Text] [Related]
5. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
Pronzato P; Vaira F; Vigani A; Losardo P; Bertelli G
Anticancer Res; 1995; 15(6B):2679-82. PubMed ID: 8669846
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma.
Kang EJ; Choi YJ; Kim JS; Kim ST; Park KH; Choi IK; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
Asia Pac J Clin Oncol; 2010 Dec; 6(4):286-91. PubMed ID: 21114778
[TBL] [Abstract][Full Text] [Related]
7. [Treatment for recurrent colorectal cancer].
Matsui T; Kotake K; Koyama Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():589-92. PubMed ID: 14574962
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for colorectal cancer.
Maughan TS
Br J Cancer; 2001 Nov; 85(10):1422-4. PubMed ID: 11720422
[No Abstract] [Full Text] [Related]
10. [Clinical study of 5-Fluorouracil and l-Leucovorin therapy for 56 patients with advanced recurrent colorectal carcinoma].
Matsuda T; Ogino K; Hiroyoshi M; Fujita H; Itoh T; Toyama H; Kawai Y; Makita D; Tsunemi K; Moritomo H; Nakamura T
Gan To Kagaku Ryoho; 2006 Jun; 33(6):783-7. PubMed ID: 16770097
[TBL] [Abstract][Full Text] [Related]
11. [Combination of 5-fluorouracil and high doses of folinic acid in the treatment of recurrent and persistent spinocellular carcinoma of the head and neck. A phase II study].
Bacigalupo A; Benasso M; Cavallari M; Merlano M; Sampietro M; Scasso F; Pallestrini E; Barbieri A; Cantoni E; Grimaldi A
Acta Otorhinolaryngol Ital; 1988; 8(6):575-80. PubMed ID: 3266818
[No Abstract] [Full Text] [Related]
12. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
[TBL] [Abstract][Full Text] [Related]
13. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.
Marshall JL; Richmond E; DeLap RJ
Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323
[TBL] [Abstract][Full Text] [Related]
14. [Combination therapy including mutamycin (mitomycin C) in the treatment of advanced colorectal and gastric cancer].
Manziuk LV; Artamonova EV; Sholokhov VN; Strygina EA
Vopr Onkol; 2001; 47(6):736-9. PubMed ID: 11826500
[TBL] [Abstract][Full Text] [Related]
15. Another study of how to give fluorouracil?
Saltz LB
J Clin Oncol; 2003 Oct; 21(20):3711-2. PubMed ID: 12963699
[No Abstract] [Full Text] [Related]
16. [Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma].
Natali M; D'Aprile M; Tonini G; Leggio M; Vici P; Carpano S; Angelini F; Carassai A; Lopez M
Clin Ter; 1990 Jul; 134(1):25-30. PubMed ID: 2147605
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
Alberts SR; Horvath WL; Sternfeld WC; Goldberg RM; Mahoney MR; Dakhil SR; Levitt R; Rowland K; Nair S; Sargent DJ; Donohue JH
J Clin Oncol; 2005 Dec; 23(36):9243-9. PubMed ID: 16230673
[TBL] [Abstract][Full Text] [Related]
18. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
[No Abstract] [Full Text] [Related]
19. A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.
Xu N; Fang WJ; Zhang XC; Yu LF; Bao HY; Shi GM; Huang S; Shen P
Cancer Invest; 2007; 25(7):599-605. PubMed ID: 17882631
[TBL] [Abstract][Full Text] [Related]
20. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
Nobile MT; Barzacch MC; Sanguineti O; Chiara S; Gozza A; Vincenti M; Lavarello A; Cognein P; Lionetto R; Percivale PL; Bertoglio S; Murolo C; Esposito M; Vannozzi MO; Rosso R
Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
